Teranishi et al. [37] reported that the PI3K-Akt signaling pathway plays an essential role in peritoneal metastasis and that PI3K inhibitors such as wortmannin can be novel modalities to prevent peritoneal metastasis of invasive cancers such as pancreatic cancer. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.